Release Date: 13/09/23 17:57 Summary: Half Year Report Ended 30 June 2023 (Price Sensitive) Price Sensitive: Yes Download Document 1.31MB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status